Learn more about racial disparities in hereditary cancer clinical trials in this discussion presented by the Basser Center for BRCA’s Black & BRCA initiative. This conversation features Ashley Dedmon, a patient advocate and member of the Basser Young Leadership Council, and Armenta Washington, a Senior Research Coordinator at Penn Medicine’s Community Outreach and Engagement Program.

Basser Center Executive Director, Susan Domchek, MD, and Roger Greenberg, MD, PhD, discuss recent advancements in BRCA-related research. Dr. Greenberg is the Basser Center's Director of Basic Science and Associate Professor in the Department of Cancer Biology at the University of Pennsylvania.

Susan Domchek, MD, discussed recent advancements in BRCA-related research. Dr. Domchek is the Basser Center's Executive Director, Basser Professor in Oncology at the University of Pennsylvania, and Director of the Marianne and Robert MacDonald Cancer Risk Evaluation Center.

Susan Domchek, MD, discussed recent advancements in BRCA-related research. Dr. Domchek is the Basser Center's Executive Director, Basser Professor in Oncology at the University of Pennsylvania, and Director of the Marianne and Robert MacDonald Cancer Risk Evaluation Center.

Basser Center Executive Director Susan Domchek, MD, presents a webinar on recent advancements in BRCA-related research. Dr. Domchek discusses recent clinical trials and scientific advancements, and breakthroughs in cancer treatment such as current FDA approvals.

In the Basser Center's Annual Research Webinar, Executive Director Susan Domchek, MD, covers the latest updates in hereditary cancer care, BRCA research, and genetics, addressing advances in 2020 and exploring options for the future.

Penn Medicine oncologist and Basser Center researcher Vivek Narayan, MD, MS, discusses BRCA-related prostate cancer treatment, recent scientific innovations, and the importance of philanthropy.

Basser Center Executive Director Susan Domchek, MD, discusses what she hopes will be the next advances in BRCA-related research and hereditary cancer care, including liquid biopsies and determining individualized risk.

At the 2020 Basser Scientific Symposium, Global Prize winners Douglas Easton, PhD, and Antonis Antoniou, Phd, from Cambridge University, presented their keynote addresses.